GO:0016896 RNA exonuclease activity, producing 5'-phosphomonoesters: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0016896 describes the molecular function of hydrolyzing RNA ester linkages from either the 3' or 5' end to release 5'-phosphomonoester nucleotides.
• This activity is essential for RNA maturation, quality control, and turnover, and is conserved from bacteria to humans.
• Key enzymes include RNase II, RNase R, XRN1, XRN2, and HELZ2, which remove nucleotides processively or distributively.
• Dysregulation of exoribonucleases is linked to cancer, cardiovascular disease, and impaired RNA quality control.
• CRISPR knockout, point mutation, knock-in, and overexpression models enable precise dissection of exoribonuclease function in cells.
• EDITGENE provides custom cell models and CRISPR library screening to study RNA exonuclease activity in disease and development.
Description
RNA exonuclease activity, producing 5'-phosphomonoesters (GO:0016896) is a fundamental molecular function that removes nucleotides from the 3' or 5' end of RNA molecules, generating 5'-phosphomonoester products. This activity is central to RNA processing, degradation, and quality control pathways that maintain cellular RNA homeostasis. Researchers study this term to understand how cells regulate transcript stability, eliminate aberrant RNAs, and respond to environmental stress. The function is carried out by a diverse set of exoribonucleases that are conserved across all kingdoms of life, from bacteria to humans. In eukaryotes, these enzymes participate in processes such as nonsense-mediated decay, rRNA processing, and the turnover of circular RNAs. In prokaryotes, they are critical for mRNA decay and maturation of stable RNAs. The importance of this activity is underscored by its links to human diseases, including cancer and cardiovascular disorders. Understanding the molecular mechanisms and regulation of 5'-phosphomonoester-producing exoribonucleases is therefore a major focus of biomedical research.
RNA exonuclease activity, producing 5'-phosphomonoesters At A Glance
| GO ID | GO:0016896 |
|---|---|
| GO term | RNA exonuclease activity, producing 5'-phosphomonoesters |
| Ontology | molecular_function |
| Synonym | exoribonuclease activity, producing 5' phosphomonoesters; exoribonuclease activity, producing 5'-phosphomonoesters |
| Definition | Catalysis of the hydrolysis of ester linkages within ribonucleic acids by removing nucleotide residues from the 3' or 5' end to yield 5' phosphomonoesters. |
| Major function | RNA degradation and processing from the 3' or 5' end, generating 5'-phosphomonoester nucleotides. |
| Related processes | RNA turnover, quality control, maturation of rRNA and other stable RNAs, and degradation of circular RNAs. |
| Representative enzymes | RNase II, RNase R, XRN1, XRN2, HELZ2, and other DEDD or RNB family exoribonucleases. |
What Is GO:0016896?
GO:0016896 is defined as the catalysis of the hydrolysis of ester linkages within ribonucleic acids by removing nucleotide residues from the 3' or 5' end to yield 5' phosphomonoesters. In other words, it is an exoribonuclease activity that cleaves RNA progressively from either terminus, releasing nucleotides that carry a phosphate group on the 5' carbon. This distinguishes it from endoribonucleases, which cut internally, and from exonucleases that produce other products such as 5'-hydroxyl or 3'-phosphate ends.
Why Is RNA exonuclease activity, producing 5'-phosphomonoesters Important in Cell Biology?
RNA exonuclease activity producing 5'-phosphomonoesters is essential for maintaining the correct balance of RNA species in cells, and its dysregulation can lead to severe physiological consequences. This activity ensures the removal of defective or excess transcripts, participates in the maturation of functional RNAs, and contributes to the cellular response to stress. Because many viruses and cancer cells exploit or are affected by exoribonuclease pathways, these enzymes are attractive targets for therapeutic intervention.
• Maintains RNA quality control by degrading aberrant or misfolded RNAs.
• Participates in the maturation of ribosomal RNA and other stable RNAs.
• Regulates the half-life of mRNAs, influencing gene expression programs.
• Controls the abundance of circular RNAs, which are implicated in cardiovascular diseases.
• Plays a role in the cellular response to TOR inhibition and stress.
• Contributes to viral RNA resistance to nucleases across kingdoms.
• Is linked to cancer through altered RNA stability and degradation.
• Provides targets for CRISPR-based functional studies and drug discovery.
• Enables precise mapping of 5'-monophosphorylated RNA ends for transcriptome analysis.
• Is conserved in bacteria, where it is essential for mRNA decay and RNA processing.
What Happens During RNA exonuclease activity, producing 5'-phosphomonoesters?
Substrate recognition and binding
In simple terms: The enzyme first grabs the end of an RNA molecule.
Exoribonucleases that produce 5'-phosphomonoesters recognize their RNA substrates through specific domains that bind the 3' or 5' terminus. For 3'-5' exoribonucleases such as RNase II and RNase R, the RNA is threaded into a central channel where the terminal nucleotide is positioned at the active site. In contrast, 5'-3' exoribonucleases like XRN1 and XRN2 require a 5'-monophosphate end for efficient binding and catalysis. The specificity for the correct end is determined by structural elements and accessory proteins that ensure processive degradation.
Catalytic hydrolysis and product release
In simple terms: The enzyme cuts off one nucleotide at a time, leaving a phosphate on the 5' end.
The catalytic mechanism involves a two-metal-ion-dependent hydrolysis of the phosphodiester bond, which releases a nucleotide 5'-monophosphate. This reaction is processive for many exoribonucleases, allowing them to remove multiple nucleotides without dissociating from the RNA. The product, a 5'-phosphomonoester, is then released and can be further metabolized or recycled. Structural studies of RNB family enzymes such as HELZ2 have revealed conserved active-site residues that coordinate the metal ions and stabilize the transition state.
Processivity and termination
In simple terms: Some enzymes keep chewing until they hit a roadblock or the RNA is gone.
Processivity is a key feature of many exoribonucleases, enabling efficient degradation of long RNAs. However, secondary structures, RNA modifications, or bound proteins can stall the enzyme and lead to termination. For example, 18S and 25S rRNA molecules can become exonuclease-resistant through 5'-end modification during TOR inhibition. Similarly, certain viral RNA folds confer nuclease resistance across kingdoms. These termination events are important for generating stable RNA fragments with regulatory functions.
Coupling to RNA decay and quality control
In simple terms: The cutting is part of a larger system that decides which RNAs live or die.
Exoribonuclease activity is often coupled to other RNA decay factors, such as helicases, decapping enzymes, and the exosome complex. In bacteria, RNase II and RNase R work with other enzymes to degrade mRNA and process stable RNAs. In eukaryotes, XRN1 and XRN2 participate in nonsense-mediated decay, rRNA processing, and transcription termination. The 5'-monophosphorylated ends generated by these enzymes can be mapped genome-wide to reveal nascent RNA transcripts and decay intermediates.
Key Genes Involved in GO:0016896 RNA exonuclease activity, producing 5'-phosphomonoesters
The following genes encode enzymes or associated factors that carry out or regulate RNA exonuclease activity producing 5'-phosphomonoesters.
| Gene | Major Role | Research Relevance |
|---|---|---|
| XRN1 | 5'-3' exoribonuclease that degrades decapped mRNAs and processes rRNA | Key model for RNA decay and quality control studies |
| XRN2 | 5'-3' exoribonuclease involved in transcription termination and rRNA processing | Target for studying nascent RNA 5'-ends and termination |
| HELZ2 | 3'-5' exoribonuclease of the RNB family, interferon-regulated | Model for interferon response and RNA turnover |
| RNase II (rnb) | 3'-5' exoribonuclease in bacteria, major mRNA decay enzyme | Bacterial model for RNA degradation |
| RNase R (rnr) | 3'-5' exoribonuclease that degrades structured RNAs | Model for RNA quality control and stress response |
| DIS3 | Catalytic subunit of the exosome with 3'-5' exoribonuclease activity | Implicated in cancer and RNA processing |
| EXOSC10 | Exosome component with 3'-5' exoribonuclease activity | Studied in rRNA processing and disease |
| PNPT1 | Polyribonucleotide nucleotidyltransferase, 3'-5' exoribonuclease | Mitochondrial RNA decay and disease models |
| ISG20 | Interferon-stimulated 3'-5' exoribonuclease | Antiviral response and RNA turnover |
| ERI1 | 3'-5' exoribonuclease involved in histone mRNA degradation | Cell cycle and RNA stability studies |
| XRN1 paralogs | Variant exoribonucleases in different organisms | Comparative genomics and evolution |
| DEDD family members | Exoribonucleases with DEDD catalytic motifs | Structural and mechanistic studies |
| RNB family members | Bacterial and eukaryotic 3'-5' exoribonucleases | Broadly conserved RNA decay |
| Caf1 | Component of the Ccr4-Not complex with 3'-5' exoribonuclease activity | mRNA deadenylation and decay |
| Rrp6 | Nuclear exosome-associated 3'-5' exoribonuclease | Nuclear RNA surveillance |
| Rrp44 | Exosome catalytic subunit in yeast | Model for exosome function |
| PARN | Poly(A)-specific 3'-5' exoribonuclease | mRNA stability and cancer |
| ANGEL2 | 2'-phosphatase and exoribonuclease involved in tRNA processing | RNA modification and disease |
How Is RNA exonuclease activity, producing 5'-phosphomonoesters Regulated?
RNA exonuclease activity producing 5'-phosphomonoesters is regulated at multiple levels, including transcription, post-translational modification, and interaction with accessory proteins. For example, HELZ2 is an interferon-regulated exoribonuclease, linking its expression to immune signaling. The activity of XRN1 and XRN2 can be modulated by phosphorylation and by binding partners that target them to specific RNA substrates. In bacteria, the availability of RNase II and RNase R is controlled by growth conditions and stress. Additionally, TOR inhibition leads to 5'-end modification of rRNA that confers resistance to exonucleases, revealing a layer of regulation through RNA modification.
RNA exonuclease activity, producing 5'-phosphomonoesters and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| XRN1 | Cancer, RNA decay dysregulation | CRISPR knockout in cancer cell lines |
| XRN2 | Transcription termination defects, cancer | Point mutation knock-in in HEK293 |
| HELZ2 | Interferon response, metabolic disorders | Overexpression in hepatocytes |
| DIS3 | Multiple myeloma, RNA processing defects | Knockout in plasma cells |
| ISG20 | Antiviral response | Knockout in macrophages |
Cancer
Altered expression of exoribonucleases such as XRN1, XRN2, and DIS3 has been observed in various cancers, where they can affect the stability of oncogenic or tumor suppressor transcripts. For instance, circular RNAs, which are regulated by exoribonucleases, are implicated in cancer progression and cardiovascular diseases. Targeting these enzymes with CRISPR knockout models can reveal their roles in tumor cell proliferation and survival.
Cardiovascular disease
Circular RNAs are abundant in the heart and their dysregulation is associated with cardiovascular diseases. Because exoribonucleases control circular RNA turnover, changes in their activity can contribute to disease pathogenesis. Studying these enzymes in cardiomyocyte models may uncover new therapeutic targets.
Viral infections and immune response
Some viruses exploit exoribonuclease-resistant RNA structures to evade degradation, while host exoribonucleases such as ISG20 and HELZ2 are interferon-stimulated and restrict viral replication. Understanding how viral RNA folds confer nuclease resistance across kingdoms can inform antiviral strategies.
Ribosomopathies and stress responses
Exoribonucleases are critical for rRNA processing, and their dysfunction can lead to ribosomopathies. TOR inhibition induces 5'-end modification of rRNA that makes it exonuclease-resistant, linking nutrient sensing to RNA stability. This pathway may be relevant in diseases characterized by ribosomal stress.
From RNA exonuclease activity, producing 5'-phosphomonoesters-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of XRN1 affect mRNA stability? | CRISPR knockout in HeLa or HEK293 cells |
| How does a point mutation in the catalytic site alter exoribonuclease activity? | Point mutation knock-in using CRISPR |
| What is the effect of tagging endogenous XRN2 on its localization? | Tagged knock-in (e.g., GFP) |
| Does overexpression of HELZ2 enhance interferon response? | Overexpression in cell lines |
| Which genes modulate sensitivity to exoribonuclease inhibition? | CRISPR library screening |
| How does TOR inhibition alter rRNA exonuclease resistance? | Knockout of TOR pathway genes in yeast |
How to Study the RNA exonuclease activity, producing 5'-phosphomonoesters Process
| Method | What It Measures | Typical Application |
|---|---|---|
| 5'-end mapping (e.g., GMUCT) | Positions of 5'-monophosphorylated RNA ends | Identifying exoribonuclease cleavage sites |
| RNA-seq | Steady-state RNA levels | Measuring transcript stability after knockout |
| Ribo-seq | Translation efficiency and ribosome footprints | Linking exoribonuclease activity to translation |
| Proteomics (AP-MS) | Protein-protein interactions | Finding exoribonuclease complex partners |
| CRISPR knockout screening | Gene essentiality and synthetic lethality | Discovering modifiers of exoribonuclease function |
| Northern blot | Size and abundance of specific RNAs | Detecting rRNA processing intermediates |
| In vitro exonuclease assay | Enzymatic activity on synthetic RNA | Characterizing mutant enzymes |
| Circular RNA quantification | Levels of circular RNAs | Studying exoribonuclease impact on circRNA turnover |
Genome-wide mapping of 5'-monophosphorylated RNA ends
This method identifies the exact 5' ends of RNA molecules generated by exoribonuclease activity, allowing researchers to map nascent transcripts and decay intermediates. It is particularly useful for studying 5'-3' exoribonucleases like XRN1 and XRN2.
RNA sequencing and Ribo-seq
RNA-seq can quantify changes in transcript abundance upon exoribonuclease perturbation, while Ribo-seq provides information on translation efficiency. These approaches help link exoribonuclease activity to gene expression programs.
Proteomics and interactomics
Affinity purification coupled to mass spectrometry can identify proteins that interact with exoribonucleases, revealing regulatory complexes. This is valuable for understanding how HELZ2 and other enzymes are targeted to specific RNAs.
CRISPR-based functional screens
Pooled CRISPR knockout libraries can be used to screen for genes that modify sensitivity to exoribonuclease inhibitors or that synthetic-lethal with exoribonuclease loss. Such screens can uncover new components of RNA decay pathways.
How CRISPR Can Be Used to Study GO:0016896 RNA exonuclease activity, producing 5'-phosphomonoesters
Knockout
CRISPR knockout of genes encoding exoribonucleases such as XRN1 or HELZ2 can reveal their essential roles in RNA decay and cell viability. Knockout cell lines are valuable for studying the accumulation of specific RNA species and for identifying compensatory pathways.
Point Mutation
Introducing point mutations in catalytic residues of exoribonucleases allows researchers to separate enzymatic activity from other functions, such as protein-protein interactions. This is particularly useful for dissecting the contribution of 5'-phosphomonoester production to RNA metabolism.
Knock-in
Knock-in of epitope tags or fluorescent proteins at endogenous loci enables real-time imaging and biochemical purification of exoribonucleases. Tagged knock-in models help track the localization and dynamics of these enzymes in living cells.
Overexpression
Overexpression of wild-type or mutant exoribonucleases can be used to test gain-of-function effects on RNA stability and cellular phenotypes. This approach is useful for studying interferon-regulated enzymes like HELZ2.
How EDITGENE Supports RNA exonuclease activity, producing 5'-phosphomonoesters Research
Researchers studying RNA exonuclease activity, producing 5'-phosphomonoesters-related genes often need to determine whether a candidate gene is causally involved in RNA metabolism, disease, or drug response. EDITGENE provides a comprehensive suite of CRISPR-based services to generate precisely engineered cell models for such investigations.
Contact EDITGENE today to design your custom CRISPR model for RNA exonuclease activity, producing 5'-phosphomonoesters research.
Frequently Asked Questions About RNA exonuclease activity, producing 5'-phosphomonoesters
What is RNA exonuclease activity, producing 5'-phosphomonoesters?
It is a molecular function (GO:0016896) that removes nucleotides from the 3' or 5' end of RNA, releasing 5'-phosphomonoester products.
What genes are involved in RNA exonuclease activity, producing 5'-phosphomonoesters?
Key genes include XRN1, XRN2, HELZ2, RNase II, RNase R, DIS3, and ISG20, among others.
What is the difference between 5'-3' and 3'-5' exoribonucleases?
5'-3' exoribonucleases like XRN1 degrade RNA from the 5' end, while 3'-5' enzymes like RNase II degrade from the 3' end, both producing 5'-phosphomonoesters.
How is RNA exonuclease activity regulated?
It is regulated by transcription, post-translational modifications, interacting proteins, and RNA modifications such as 5'-end changes during TOR inhibition.
What diseases are associated with defects in RNA exonuclease activity?
Dysregulation is linked to cancer, cardiovascular diseases, viral infections, and ribosomopathies.
What methods are used to study RNA exonuclease activity?
Common methods include 5'-end mapping, RNA-seq, Ribo-seq, proteomics, and CRISPR screens.
Can CRISPR be used to study RNA exonuclease activity?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models are widely used to dissect gene function.
What is the role of XRN1 in RNA decay?
XRN1 is a major 5'-3' exoribonuclease that degrades decapped mRNAs and processes ribosomal RNA.
How does HELZ2 function as an exoribonuclease?
HELZ2 is an interferon-regulated 3'-5' exoribonuclease of the RNB family that contributes to RNA turnover.
Why is 5'-phosphomonoester production important?
It marks RNA ends for further processing or degradation and is essential for RNA quality control and turnover.
Conclusion
RNA exonuclease activity, producing 5'-phosphomonoesters (GO:0016896) is a cornerstone of RNA metabolism, ensuring the proper processing and degradation of transcripts across all domains of life. Its dysregulation has been implicated in cancer, cardiovascular disease, and immune responses, making it a compelling target for basic and translational research. By leveraging CRISPR-based models and advanced RNA methodologies, researchers can uncover new layers of regulation and identify therapeutic opportunities.
References
- 1. Jeck WR et al.. 2013. Circular RNAs are abundant, conserved, and associated with ALU repeats.. RNA 19(2):141-57 PMID: 23249747
- 2. Huntzinger E et al.. 2023. HELZ2: a new, interferon-regulated, human 3'-5' exoribonuclease of the RNB family is expressed from a non-canonical initiation codon.. Nucleic Acids Res 51(17):9279-9293 PMID: 37602378
- 3. Mei X et al.. 2022. Circular RNAs in cardiovascular diseases.. Pharmacol Ther 232:107991 PMID: 34592203
- 4. Rocha MA et al.. 2025. 18S and 25S Exonuclease Resistant Ribosomal RNA Molecules Are Produced by 5'-End Modification During TOR Inhibition.. Yeast 42(12):273-282 PMID: 41195863
- 5. Mayle R et al.. 2025. DNA polymerase α-primase can function as a translesion DNA polymerase.. Proc Natl Acad Sci U S A 122(37):e2517556122 PMID: 40928879
- 6. Gezelle JG et al.. 2025. A conserved viral RNA fold enables nuclease resistance across kingdoms of life.. Nucleic Acids Res 53(16) PMID: 40884403
- 7. Mohanty BK et al.. 2018. Enzymes Involved in Posttranscriptional RNA Metabolism in Gram-Negative Bacteria.. Microbiol Spectr 6(2) PMID: 29676246
- 8. Cortázar MA et al.. 2023. Genome-wide Mapping of 5'-monophosphorylated Ends of Mammalian Nascent RNA Transcripts.. Bio Protoc 13(18):e4828 PMID: 37753464
